Main Menu
Publish World Outlook Learn


  • There are forecasts that menopausal women would reach over 1 billion by 2025. TimesNext
  • Osteoporosis affects both men and women of all races but Asian women especially, post menopausal are at high risk. The Pioneer
  • Investors are beginning to realize that menopause care is ripe for innovation, validating the massive menopause market spending opportunity which has been valued at $600 billion by Female Founders Fund. Mobihealthnews
  • Encompassing a broad range of services, from fertility and menopause to sexual wellness, the femtech market is expected to be worth $60bn by 2027. Sifted
  • Menopause - which represents a $600 billion global market opportunity - is a universal experience that impacts every aspect of a woman's health: mental, physical, and emotional. HIT Consultant Media
  • The link between low estrogen and impaired hearing suggests that women who arrive at menopause later, at age 50 or older - 51 is the average age of menopause in the United States-might have a lower risk of hearing loss. Healthy Hearing
  • White and Asian women, especially older women who are past menopause, are at highest risk.
  • The global vaginal moisturizers and lubricants market is expected to experience significant growth, owing to the increased awareness of women about sexual health. Market Data Forecast
  • In summary, age, BMI, and menopausal status are common risk factors for osteoporosis in diabetic and non-diabetic patients. Frontiers
  • There are many negative health consequences linked to early menopause, including a higher risk of osteoporosis and fracture, heart disease, cognitive impairment and dementia, and early death.
  • Other risk factors include older age, race (Black women are at higher risk), obesity, a family history of fibroids, high blood pressure, no history of pregnancy, Vitamin D deficiency, and the consumption of food additives and soy milk. Parsley Health
  • Major risk factors associated with increased risk of VF in patients with PHPT were advanced age, years since menopause, and low BMD at lumbar spine and distal radius. American Society for Bone and Mineral Research
  • Startups and venture capitalists are increasingly recognizing that medical, health, and wellness treatment of menopause is a $600 billion market - and an opportunity. Thomson Reuters Institute
  • Early menstruation-periods before age 12-and starting menopause after age 55 expose women to hormones longer, raising their risk of getting breast cancer. Yahoo
  • Per studies of menopausal hormone therapy, it is likely that the progestogen in EE-containing birth control pills augments the risk of blood clots with EE. Transfeminine Science
  • Leg skin microbiome accurately predicts menopausal status: Canada cohort. Scientific Reports
  • Exogenous postmenopausal hormone use was associated with increased risk of CHIP among women in the UK Biobank who experienced menopause later in life. Circulation
  • Among women in the UK Biobank, in an exploratory model adjusted for age, the first 10 principal components of ancestry, and smoking status, premature menopause was associated with 3-fold risk for myeloid dysplasia and neoplasia (hazard ratio [HR], 2.98; P = 0.04). Circulation
  • Cardiovascular disease is the leading cause of death among women in the United States and globally, 1 and cardiovascular risk increases substantially after menopause. Circulation
  • A potential first-in-class treatment for menopausal symptoms came to Bayer through its $425 million upfront acquisition of KaNDy Therapeutics last year, and it's expected to enter phase 3 trial in 2021. FiercePharma
  • The menopause market is predicted to reach $5.28 billion by 2023. UKTN (UK Tech News)
  • Kandy's drug NT-814 is expected to start a final-stage clinical trial next year and could generate peak sales of 1 billion euros ($1.17 billion) globally.

Last updated: 19 September 2021